ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,286Medicare Part D Prescriptions Filled, Including Refills

Rank: 39 out of 103

$615K Total Retail Price of All Prescriptions

Rank: 24 out of 103

404 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 404 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 404 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,910 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
LEVOTHYROXINE SODIUM 531 486 1 1
FUROSEMIDE 411 378 2 4
OMEPRAZOLE 353 320 3 3
CITALOPRAM HBR 276 244 4 15
LISINOPRIL 263 212 5 5
TRAMADOL HCL 240 210 6 17
POTASSIUM CHLORIDE 222 206 7 10
METOPROLOL SUCCINATE 219 211 8 8
DONEPEZIL HCL 215 215 9 28
GABAPENTIN 199 170 10 22
PREDNISONE 178 123 11 24
HYDROCODONE-ACETAMINOPHEN 167 126 S3 12 11
SIMVASTATIN 165 135 13 2
METOPROLOL TARTRATE 154 141 14 9
ALENDRONATE SODIUM 139 119 15 19
METHOTREXATE 136 111 16 80
RISPERIDONE 134 134 17 88
POLYETHYLENE GLYCOL 3350 118 112 18 31
AMLODIPINE BESYLATE 113 104 19 6
NAMENDA 112 112 20 41
CARVEDILOL 108 108 21 20
SPIRONOLACTONE 101 101 22 30
METFORMIN HCL 98 87 23 13
ZOLPIDEM TARTRATE 93 85 24 29
ALLOPURINOL 92 84 25 26
CIPROFLOXACIN HCL 91 86 26 59
AZITHROMYCIN 87 68 27 44
CRESTOR 85 57 28 27
AMITRIPTYLINE HCL 82 31 R 29 54
CEPHALEXIN 81 78 30 72
ACETAMINOPHEN-CODEINE 81 69 S3 30 122
DIGOXIN 75 62 32 25
WARFARIN SODIUM 74 62 33 7
PLAVIX 69 69 34 46
FENTANYL 67 66 S2 35 34
CLOPIDOGREL 66 66 36 32
MIRTAZAPINE 66 53 36 36
LEFLUNOMIDE 64 43 38 172
CYCLOBENZAPRINE HCL 63 47 R 39 83
PANTOPRAZOLE SODIUM 62 52 40 95
GLIPIZIDE 61 61 41 65
IPRATROPIUM-ALBUTEROL 60 60 42 106
PAROXETINE HCL 59 59 43 81
DIOVAN 59 59 43 40
FLUTICASONE PROPIONATE 56 36 45 35
MELOXICAM 56 46 45 49
SERTRALINE HCL 53 52 47 21
PROPRANOLOL HCL 52 27 48 87
ISOSORBIDE MONONITRATE ER 51 51 49 37
CYMBALTA 51 38 49 60
OXYBUTYNIN CHLORIDE ER 50 50 51 74
HYDRALAZINE HCL 50 50 51 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 4, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.